The steady rise in the number of litigation cases the Pharmaceutical and Biotech industry is facing has led to budgetary increases for litigation and legal matters, which in turn means your patents are under even greater under scrutiny.

Pharmaceutical and Biotech Patent Litigation Strategies 2008 is designed to help you discover vital information needed to thrive under this scrutiny within this increasingly pressured discipline.

2008’s conference will cover the evolving trends in both Europe and the United States. Our Excellent speaker panel includes representatives from the in-house counsel of major pharmaceutical companies, biotech and generic organisations as well as outside counsel who specialise in pharmaceutical patent litigation.

Gain insights and learn from the experiences of speakers from:
> Merck Serono SA
> Novartis
> Merck Generics
> Ribovax
> Merck, Sharpe & Dohme
> GlaxoSmithKline